- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 411/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Patent holdings for IPC class C07D 411/14
Total number of patents in this class: 161
10-year publication summary
|
10
|
4
|
15
|
17
|
17
|
12
|
8
|
13
|
12
|
12
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10263 |
9 |
| LG Chem, Ltd. | 17921 |
7 |
| MyoKardia, Inc. | 113 |
6 |
| Pramana Pharmaceuticals Inc. | 6 |
6 |
| BASF SE | 21303 |
5 |
| Duk San Neolux Co., Ltd. | 703 |
5 |
| Guangzhou Tinci Materials Technology Co., Ltd. | 158 |
4 |
| LT Materials Co., Ltd. | 444 |
4 |
| Janssen Pharmaceutica N.V. | 3171 |
3 |
| FUJIFILM Corporation | 30512 |
3 |
| Infinity Pharmaceuticals, Inc. | 96 |
3 |
| Otsuka Pharmaceutical Co., Ltd. | 1501 |
3 |
| Syros Pharmaceuticals, Inc. | 65 |
3 |
| University of Maryland, Baltimore County | 281 |
3 |
| Shaanxi Lighte Optoelectronics Material Co., Ltd. | 317 |
3 |
| Bristol-myers Squibb Company | 4729 |
2 |
| Merck Sharp & Dohme Corp. | 2183 |
2 |
| E. I. du Pont de Nemours and Company | 3542 |
2 |
| Boehringer Ingelheim International GmbH | 4493 |
2 |
| Syngenta Participations AG | 1527 |
2 |
| Other owners | 84 |